Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

High Resolution Discovery Proteomics Reveals Candidate Disease Progression Markers of Alzheimer's Disease in Human Cerebrospinal Fluid.

Hendrickson RC, Lee AY, Song Q, Liaw A, Wiener M, Paweletz CP, Seeburger JL, Li J, Meng F, Deyanova EG, Mazur MT, Settlage RE, Zhao X, Southwick K, Du Y, Holder D, Sachs JR, Laterza OF, Dallob A, Chappell DL, Snyder K, Modur V, King E, Joachim C, Bondarenko AY, Shearman M, Soper KA, Smith AD, Potter WZ, Koblan KS, Sachs AB, Yates NA.

PLoS One. 2015 Aug 13;10(8):e0135365. doi: 10.1371/journal.pone.0135365. eCollection 2015.

2.

Spatial component analysis of MRI data for Alzheimer's disease diagnosis: a Bayesian network approach.

Illan IA, Górriz JM, Ramírez J, Meyer-Base A.

Front Comput Neurosci. 2014 Nov 26;8:156. doi: 10.3389/fncom.2014.00156. eCollection 2014.

3.

An ensemble-of-classifiers based approach for early diagnosis of Alzheimer's disease: classification using structural features of brain images.

Farhan S, Fahiem MA, Tauseef H.

Comput Math Methods Med. 2014;2014:862307. doi: 10.1155/2014/862307. Epub 2014 Sep 9.

4.

The appropriate use of neuroimaging in the diagnostic work-up of dementia: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2014 Feb 1;14(1):1-64. eCollection 2014. Review.

5.

Regional amyloid deposition in amnestic mild cognitive impairment and Alzheimer's disease evaluated by [18F]AV-45 positron emission tomography in Chinese population.

Huang KL, Lin KJ, Hsiao IT, Kuo HC, Hsu WC, Chuang WL, Kung MP, Wey SP, Hsieh CJ, Wai YY, Yen TC, Huang CC.

PLoS One. 2013;8(3):e58974. doi: 10.1371/journal.pone.0058974. Epub 2013 Mar 14.

6.

Effective diagnosis of Alzheimer's disease by means of large margin-based methodology.

Chaves R, Ramírez J, Górriz JM, Illán IA, Gómez-Río M, Carnero C; Alzheimer’s Disease Neuroimaging Initiative.

BMC Med Inform Decis Mak. 2012 Jul 31;12:79. doi: 10.1186/1472-6947-12-79.

7.

Accuracy of the clinical diagnosis of Alzheimer disease at National Institute on Aging Alzheimer Disease Centers, 2005-2010.

Beach TG, Monsell SE, Phillips LE, Kukull W.

J Neuropathol Exp Neurol. 2012 Apr;71(4):266-73. doi: 10.1097/NEN.0b013e31824b211b.

8.

Evolution of the diagnostic criteria for degenerative and cognitive disorders.

Lopez OL, McDade E, Riverol M, Becker JT.

Curr Opin Neurol. 2011 Dec;24(6):532-41. doi: 10.1097/WCO.0b013e32834cd45b. Review.

9.

Sensitivity and specificity of neuroimaging for the diagnosis of Alzheimer's disease.

Wollman DE, Prohovnik I.

Dialogues Clin Neurosci. 2003 Mar;5(1):89-99.

10.

Diagnosis of Alzheimer's disease based on disease-specific autoantibody profiles in human sera.

Nagele E, Han M, Demarshall C, Belinka B, Nagele R.

PLoS One. 2011;6(8):e23112. doi: 10.1371/journal.pone.0023112. Epub 2011 Aug 3.

11.

FDG- and amyloid-PET in Alzheimer's disease: is the whole greater than the sum of the parts?

Mosconi L, McHugh PF.

Q J Nucl Med Mol Imaging. 2011 Jun;55(3):250-64. Review.

12.

TC-99m HMPAO Brain Blood Flow Imaging in the Dementias with Histopathologic Correlation in 73 Patients.

Bonte FJ, Hynan L, Harris TS, White CL 3rd.

Int J Mol Imaging. 2011;2011:409101. doi: 10.1155/2011/409101. Epub 2010 Dec 1.

13.

Reducing case ascertainment costs in U.S. population studies of Alzheimer's disease, dementia, and cognitive impairment-Part 1.

Weir DR, Wallace RB, Langa KM, Plassman BL, Wilson RS, Bennett DA, Duara R, Loewenstein D, Ganguli M, Sano M.

Alzheimers Dement. 2011 Jan;7(1):94-109. doi: 10.1016/j.jalz.2010.11.004.

14.

The art of sharing the diagnosis and management of Alzheimer's disease with patients and caregivers: recommendations of an expert consensus panel.

Grossberg GT, Christensen DD, Griffith PA, Kerwin DR, Hunt G, Hall EJ.

Prim Care Companion J Clin Psychiatry. 2010;12(1):PCC.09cs00833. doi: 10.4088/PCC.09cs00833oli.

15.

Reliability and validity of an algorithm for the diagnosis of normal cognition, mild cognitive impairment, and dementia: implications for multicenter research studies.

Duara R, Loewenstein DA, Greig M, Acevedo A, Potter E, Appel J, Raj A, Schinka J, Schofield E, Barker W, Wu Y, Potter H.

Am J Geriatr Psychiatry. 2010 Apr;18(4):363-70.

16.

Neuropsychological assessment in the diagnosis of Alzheimer's disease.

Baldwin S, Farias ST.

Curr Protoc Neurosci. 2009 Oct;Chapter 10:Unit10.3. doi: 10.1002/0471142301.ns1003s49. Review.

17.

Structural MRI discriminates individuals with Mild Cognitive Impairment from age-matched controls: a combined neuropsychological and voxel based morphometry study.

Trivedi MA, Wichmann AK, Torgerson BM, Ward MA, Schmitz TW, Ries ML, Koscik RL, Asthana S, Johnson SC.

Alzheimers Dement. 2006 Oct;2(4):296-302. doi: 10.1016/j.jalz.2006.06.001.

18.

Consortium to Establish a Registry for Alzheimer's Disease (CERAD): the first twenty years.

Fillenbaum GG, van Belle G, Morris JC, Mohs RC, Mirra SS, Davis PC, Tariot PN, Silverman JM, Clark CM, Welsh-Bohmer KA, Heyman A.

Alzheimers Dement. 2008 Mar;4(2):96-109. doi: 10.1016/j.jalz.2007.08.005.

19.

Automatic volumetry on MR brain images can support diagnostic decision making.

Heckemann RA, Hammers A, Rueckert D, Aviv RI, Harvey CJ, Hajnal JV.

BMC Med Imaging. 2008 May 23;8:9. doi: 10.1186/1471-2342-8-9.

20.

Ways toward an early diagnosis in Alzheimer's disease: the Alzheimer's Disease Neuroimaging Initiative (ADNI).

Mueller SG, Weiner MW, Thal LJ, Petersen RC, Jack CR, Jagust W, Trojanowski JQ, Toga AW, Beckett L.

Alzheimers Dement. 2005 Jul;1(1):55-66.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk